Does ABIRATERONE Cause Therapy cessation? 1,602 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,602 reports of Therapy cessation have been filed in association with ABIRATERONE (Abiraterone Acetate). This represents 4.6% of all adverse event reports for ABIRATERONE.
1,602
Reports of Therapy cessation with ABIRATERONE
4.6%
of all ABIRATERONE reports
17
Deaths
123
Hospitalizations
How Dangerous Is Therapy cessation From ABIRATERONE?
Of the 1,602 reports, 17 (1.1%) resulted in death, 123 (7.7%) required hospitalization, and 5 (0.3%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABIRATERONE. However, 1,602 reports have been filed with the FAERS database.
What Other Side Effects Does ABIRATERONE Cause?
Death (5,623)
Fatigue (1,928)
Drug ineffective (1,732)
Prostatic specific antigen increased (1,581)
Disease progression (1,098)
Hospitalisation (1,034)
Hot flush (989)
Asthenia (891)
Off label use (859)
Fall (804)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
SECUKINUMAB (620)
Which ABIRATERONE Alternatives Have Lower Therapy cessation Risk?
ABIRATERONE vs ABIRATERONE\ABIRATERONE
ABIRATERONE vs ABOBOTULINUMTOXINA
ABIRATERONE vs ABRAXANE
ABIRATERONE vs ABROCITINIB
ABIRATERONE vs ACALABRUTINIB